[The problem of quality of medications at Russian market (1992-2004). Report II. The control of new and serially produced medications].

The archives of the Ministry of Health Care of Russia, journal publications, interviews and memoirs testify that issue of medications quality was key issue in life of Russian Pharma in 1992-2004. The support of medication safety considered not only as part of social policy, but also as rules that could be used to reformat the "wild bazaar" into "controlled market". The media disputes, departmental justifications, political bills and memoirs give idea about "price of the issue" (heat of emotions, ambitions, financial losses).

[Treatment of children with blunt spleen injury throughout 25-year period in Sevastopol and the Republic of Crimea].

Objective: This study examines methods of treatment of pediatric patients with blunt splenic injury (BSI) in medical institutions in the city of Sevastopol and the Republic of Crimea. The effectiveness of non-operative management (NOM) in patients with BSI of varying AAST injury grade was assessed and risk factors which could predict the need for operative management (OM) were identified.

Material And Methods: A two-center retrospective cohort study was performed, in which reviewed the medical records of children diagnosed with BSI between 1996 and 2023.

[The problem of quality of medications at Russian market (1992-2004). Report I. The control systems].

The archives of Ministry of Health of Russia, journal publications, interviews and memoirs testify that issue of quality of medications was key one in life of Russian Pharma in 1992-2004. The drug safety support considered not only as part of social policy, but also as rules that could be used to reformat"wild bazaar" into "controlled market". The media disputes, departmental justifications, political bills and memoirs give idea about "price of the issue" - tension of emotions, ambitions, financial losses.

[The metamorphoses of denationalization of 1993. Report II. The prices of medications as information].

In the history of Russian pharmaceutical market, the year of 1993 became the year of both formation of rules of market relations and alteration of market landscape for changed conditions. The significant segment of state centralized purchases moved under responsibility of regional authorities and their health authorities. At that, authorizations of former three state organizations occupied with import purchases were distributed between new state companies of the Ministry of Health Care and commercial organizations and firms that entered pharmaceutical market.

[The metamorphoses of denationalization of 1993. Report-I. The market fight for medications import].

In the history of the Russian pharmaceutical market the year of 1993 became the year of formation of rules of market relations and changing under them of market landscape. The significant segment of state-centralized purchases moved under responsibility of regional authorities and their health care authorities. At that, powers of three former state organizations being occupied with purchases of imported medications were distributed between new state companies of Ministry of Health and commercial organizations and firms that entered pharmaceutical market.